We look forward to participating in the 6th Annual Inhalation and Respiratory Drug Delivery Conference in Barcelona this October.
This event brings together experts from pharmaceutical, medical device development, and manufacturing sectors to explore current developments in inhalation and respiratory drug delivery. Topics will include emerging device technologies, combination product development, regulatory frameworks, and collaborative strategies for advancing patient-centric solutions.
Our Application Specialist, Dr Clair Brooks, will be presenting on:
Advancing Generic Inhaled Product Development: Realistic In Vitro Approaches for Demonstrating Bioequivalence
This talk will cover:
- An overview of FDA Product-Specific Guidances (PSGs) and the increasing role of in vitro testing in bioequivalence (BE) assessments
- The principles of realistic APSD testing, including the use of patient-representative breath profiles and anatomically relevant mouth-throat models
- Key challenges such as method standardisation, reproducibility, and evolving regulatory expectations
We look forward to contributing to the discussion and connecting with industry peers during the event.
Learn more and register on the R&Y International Conference Website
